Integrated metabolomics and proteomics platforms revealed a marked increase in fatty acid oxidation-related metabolites, as well as proteome changes, in PDAC treated with GLS1 inhibitors, suggesting that treatments should target multiple metabolic pathways to overcome metabolic plasticity 112,113
Our instructor, Jean-Jacques, his left hand, he only has a thumb
George NM, Whitaker J, Vieira G, Geronimo JT, Bellinger DA, Fletcher CA, et al
Barekat F, Tavalaee M, Deemeh MR, Bahreinian M, Azadi L, Abbasi H, et al
53rd Annual Meeting Southern Thoracic Surgeons Association, 2006
In terms of cross-sectional remission, we observed the rates of 42.31% ( n = 11 of 26) a 1-month, 50% ( n = 13 of 26) at 3-months, and 60% ( n = 15 of 25) at 6 months